Diagnostic accuracy of cerebrospinal fluid and serum-isolated extracellular vesicles for glioblastoma: a systematic review and meta-analysis

References

• Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med. 2008;359(5):492–507.
   PubMed Web of Science ®Google Scholar
• Krex D, Klink B, Hartmann C, et al. Long-term survival with glioblastoma multiforme. Brain. 2007;130(Pt10):2596–2606.
   PubMedGoogle Scholar
• Kim -S-S, Harford JB, Pirollo KF, et al. Effective treatment of glioblastoma requires crossing the blood–brain barrier and targeting tumors including cancer stem cells: the promise of nanomedicine. Biochem Biophys Res Commun. 2015;468(3):485–489.
   PubMed Web of Science ®Google Scholar
• Huang SX, Shao K, Kuang YY, et al. Tumor targeting and microenvironment-responsive nanoparticles for gene delivery. Biomaterials. 2013;34(21):5294–5302.
   PubMed Web of Science ®Google Scholar
• Emery JD, Shaw K, Williams B, et al. The role of primary care in early detection and follow-up of cancer. Nat Rev Clin Oncol. 2014;11(1):38–48.
   PubMed Web of Science ®Google Scholar
• Nass D, Rosenwald S, Meiri E, et al. MiR‐92b and miR‐9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors. Brain Pathol. 2009;19(3):375–383.
   PubMed Web of Science ®Google Scholar
• Schwartz SA, Weil RJ, Thompson RC, et al. Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry. Cancer Res. 2005;65(17):7674–7681.
   PubMed Web of Science ®Google Scholar
• Khalil AA. Biomarker discovery: a proteomic approach for brain cancer profiling. Cancer Sci. 2007;98(2):201–213.
   PubMed Web of Science ®Google Scholar
• Kim JH, Kim E, Lee MY. Exosomes as diagnostic biomarkers in cancer. Mol Cell Toxicol. 2018;14(2):113–122.
   Web of Science ®Google Scholar
• Street JM, Birkhoff W, Menzies RI, et al. Exosomal transmission of functional aquaporin 2 in kidney cortical collecting duct cells. J Physiol-London. 2011;589(24):6119–6127.
   PubMed Web of Science ®Google Scholar
• Gyorgy B, Szabo TG, Pasztoi M, et al. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci. 2011;68(16):2667–2688.
   PubMed Web of Science ®Google Scholar
• Skog J, Wurdinger T, van Rijn S, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008;10(12):1470–U1209.
   PubMed Web of Science ®Google Scholar
• Théry C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the international society for extracellular vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750.
   PubMed Web of Science ®Google Scholar
• van der Pol E, Böing AN, Gool EL, et al. Recent developments in the nomenclature, presence, isolation, detection and clinical impact of extracellular vesicles. J Thromb Haemost. 2016;14(1):48–56.
   PubMed Web of Science ®Google Scholar
• Anastasiadou E, Slack FJ. Malicious exosomes. Science. 2014;346(6216):1459–1460.
   PubMed Web of Science ®Google Scholar
• Valadi H, Ekstrom K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9(6):654–U672.
   PubMed Web of Science ®Google Scholar
• Del Boccio P, Raimondo F, Pieragostino D, et al. A hyphenated microLC‐Q‐TOF‐MS platform for exosomal lipidomics investigations: application to RCC urinary exosomes. Electrophoresis. 2012;33(4):689–696.
   PubMed Web of Science ®Google Scholar
• Whiteside TL. Tumor-derived exosomes and their role in cancer progression. Adv Clin Chem. 2016;74:103–141.
   PubMed Web of Science ®Google Scholar
• Thuy MN, Kam JK, Lee GC, et al. A novel literature-based approach to identify genetic and molecular predictors of survival in glioblastoma multiforme: analysis of 14,678 patients using systematic review and meta-analytical tools. J Clin Neurosci. 2015;22(5):785–799.
   PubMed Web of Science ®Google Scholar
• McInnes MDF, Moher D, Thombs BD, et al. Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies the PRISMA-DTA statement. Jama. 2018;319(4):388–396.
   PubMed Web of Science ®Google Scholar
• Macaskill P, Gatsonis C, Deeks J, et al. Cochrane handbook for systematic reviews of diagnostic test accuracy. Version 0.9. 0. London: The Cochrane Collaboration; 2010.
   Google Scholar
• Gheytanchi E, Madjd Z, Janani L, et al. Exosomal microRNAs as potential circulating biomarkers in gastrointestinal tract cancers: a systematic review protocol. Syst Rev. 2017;6(1):228.
   PubMedGoogle Scholar
• Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–536.
   PubMed Web of Science ®Google Scholar
• Harbord RM, Deeks JJ, Egger M, et al. A unification of models for meta-analysis of diagnostic accuracy studies. Biostatistics. 2007;8(2):239–251.
   PubMed Web of Science ®Google Scholar
• Dwamena BA. midas: a program for meta-analytical integration of diagnostic accuracy studies in stata. Ann Arbor, Michigan: Division of Nuclear Medicine, Department of Radiology, University of Michigan Medical School; 2007.
   Google Scholar
• Reitsma JB, Glas AS, Rutjes AW, et al. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol. 2005;58(10):982–990.
   PubMed Web of Science ®Google Scholar
• Rutter CM, Gatsonis CA. A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med. 2001;20(19):2865–2884.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560.
   PubMed Web of Science ®Google Scholar
• Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005;58(9):882–893.
   PubMed Web of Science ®Google Scholar
• Akers JC, Ramakrishnan V, Kim R, et al. MiR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker development. PLoS One. 2013;8(10):e78115.
   PubMed Web of Science ®Google Scholar
• Tan SK, Pastori C, Penas C, et al. Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme. Mol Cancer. 2018;17(1):74.
   PubMed Web of Science ®Google Scholar
• Manterola L, Guruceaga E, Perez-Larraya JG, et al. A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool. Neuro Oncol. 2014;16(4):520–527.
   PubMed Web of Science ®Google Scholar
• Lan FM, Qing Q, Pan Q, et al. Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma. Cell Oncol. 2018;41(1):25–33.
   PubMed Web of Science ®Google Scholar
• Zhong F, Huang T, Leng J. Serum miR-29b as a novel biomarker for glioblastoma diagnosis and prognosis. Int J Clin Exp Pathol. 2019;12(11):4106–4112.
   PubMed Web of Science ®Google Scholar
• Shi R, Wang PY, Li XY, et al. Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients. Oncotarget. 2015;6(29):26971–26981.
   PubMedGoogle Scholar
• Ebrahimkhani S, Vafaee F, Hallal S, et al. Deep sequencing of circulating exosomal microRNA allows non-invasive glioblastoma diagnosis. Npj Precis Oncol. 2018;2(1):28.
   PubMedGoogle Scholar
• Akers JC, Hua W, Li HY, et al. A cerebrospinal fluid microRNA signature as biomarker for glioblastoma. Oncotarget. 2017;8(40):68769–68779.
   PubMedGoogle Scholar
• Santangelo A, Imbruce P, Gardenghi B, et al. A microRNA signature from serum exosomes of patients with glioma as complementary diagnostic biomarker. J Neuro-Oncol. 2018;136(1):51–62.
   PubMed Web of Science ®Google Scholar
• Bertram JS. The molecular biology of cancer. Mol Aspects Med. 2000;21(6):167–223.
   PubMedGoogle Scholar
• Hanash SM, Baik CS, Kallioniemi O. Emerging molecular biomarkers—blood-based strategies to detect and monitor cancer. Nat Rev Clin Oncol. 2011;8(3):142–150.
   PubMed Web of Science ®Google Scholar
• Ransohoff DF. Developing molecular biomarkers for cancer. Science. 2003;299(5613):1679–1680.
   PubMed Web of Science ®Google Scholar
• Bucy PC, Oberhill HR, Siqueira EB, et al. Cerebral glioblastomas can be cured. Neurosurgery. 1985;16(5):714–717.
   PubMed Web of Science ®Google Scholar
• Enroth S, Berggrund M, Lycke M, et al. A two-step strategy for identification of plasma protein biomarkers for endometrial and ovarian cancer. Clin Proteomics. 2018;15:38.
   PubMed Web of Science ®Google Scholar
• Bronkhorst AJ, Ungerer V, Holdenrieder S. The emerging role of cell-free DNA as a molecular marker for cancer management. Biomol Detect Quantif. 2019;17:100087.
   PubMedGoogle Scholar
• Zaporozhchenko IA, Ponomaryova AA, Rykova EY, et al. The potential of circulating cell-free RNA as a cancer biomarker: challenges and opportunities. Expert Rev Mol Diagn. 2018;18(2):133–145.
   PubMed Web of Science ®Google Scholar
• Huang T, Deng C-X. Current progresses of exosomes as cancer diagnostic and prognostic biomarkers. Int J Biol Sci. 2019;15(1):1–11.
   PubMed Web of Science ®Google Scholar
• Toiyama Y, Takahashi M, Hur K, et al. Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer. JNCI. 2013;105(12):849–859.
   PubMedGoogle Scholar
• Yaman Agaoglu F, Kovancilar M, Dizdar Y, et al. Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer. Tumor Biol. 2011;32(3):583–588.
   PubMed Web of Science ®Google Scholar
• Liu XG, Zhu WY, Huang YY, et al. High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer. Med Oncol. 2012;29(2):618–626.
   PubMed Web of Science ®Google Scholar
• Gao JJ, Zhang QY, Xu JJ, et al. Clinical significance of serum miR-21 in breast cancer compared with CA153 and CEA. Chin J Cancer Res. 2013;25(6):743–748.
   PubMed Web of Science ®Google Scholar
• Wang Y, Gao XJ, Wei F, et al. Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis. Gene. 2014;533(1):389–397.
   PubMed Web of Science ®Google Scholar
• Sukreet S, Silva BVRE, Adamec J, et al. Sonication and short-term incubation alter the content of bovine milk exosome cargos and exosome bioavailability (OR26-08-19). Curr Dev Nutr. 2019;3(Supplement_1). DOI:10.1093/cdn/nzz033.OR26-08-19
   Google Scholar
• Kanchanapally R, Deshmukh SK, Chavva SR, et al. Drug-loaded exosomal preparations from different cell types exhibit distinctive loading capability, yield, and antitumor efficacies: a comparative analysis. Int J Nanomedicine. 2019;14:531–541.
   PubMed Web of Science ®Google Scholar
• Tang YT, Huang YY, Zheng L, et al. Comparison of isolation methods of exosomes and exosomal RNA from cell culture medium and serum. Int J Mol Med. 2017;40(3):834–844.
   PubMed Web of Science ®Google Scholar
• Van Deun J, Mestdagh P, Sormunen R, et al. The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling. J Extracell Vesicles. 2014;3(1):24858.
   PubMedGoogle Scholar
• Taylor DD, Shah S. Methods of isolating extracellular vesicles impact down-stream analyses of their cargoes. Methods. 2015;87:3–10.
   PubMed Web of Science ®Google Scholar
• Zarovni N, Corrado A, Guazzi P, et al. Integrated isolation and quantitative analysis of exosome shuttled proteins and nucleic acids using immunocapture approaches. Methods. 2015;87:46–58.
   PubMed Web of Science ®Google Scholar
• Stranska R, Gysbrechts L, Wouters J, et al. Comparison of membrane affinity-based method with size-exclusion chromatography for isolation of exosome-like vesicles from human plasma. J Transl Med. 2018;16(1):1.
   PubMed Web of Science ®Google Scholar
• Rekker K, Saare M, Roost AM, et al. Comparison of serum exosome isolation methods for microRNA profiling. Clin Biochem. 2014;47(1–2):135–138.
   PubMed Web of Science ®Google Scholar
• Tauro BJ, Greening DW, Mathias RA, et al. Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes. Methods. 2012;56(2):293–304.
   PubMed Web of Science ®Google Scholar
• Eldh M, Lotvall J, Malmhall C, et al. Importance of RNA isolation methods for analysis of exosomal RNA: evaluation of different methods. Mol Immunol. 2012;50(4):278–286.
   PubMed Web of Science ®Google Scholar
• Glas AS, Lijmer JG, Prins MH, et al. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol. 2003;56(11):1129–1135.
   PubMed Web of Science ®Google Scholar
• Jones CM, Athanasiou T. Summary receiver operating characteristic curve analysis techniques in the evaluation of diagnostic tests. Ann Thorac Surg. 2005;79(1):16–20.
   PubMed Web of Science ®Google Scholar
• Song Z, Wang S, Liu Y. The diagnostic accuracy of liquid exosomes for lung cancer detection: a meta-analysis. Onco Targets Ther. 2018;12:181–192.
   PubMed Web of Science ®Google Scholar
• Bossuyt PM, Reitsma JB, Bruns DE, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ. 2015;351:h5527.
   PubMed Web of Science ®Google Scholar